Metabolic & Cardiometabolic
continuous glucose monitoring improves metabolic outcomes in metabolically healthy people
In plain terms: Should healthy people wear a CGM to prevent disease?
No trial evidence shows glycemic or health benefit from CGM in metabolically healthy people; the "everyone should wear one" claim is unsupported.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
No trial shows glycaemic or health benefit from continuous glucose monitoring in metabolically healthy people, and a meta-analysis in non-diabetic populations found no effect on glycaemic measures, weight or behaviour. The devices do produce useful reference data — healthy ranges turn out to be narrow across 7,000 adults — and may aid motivation, which is not the same as improving outcomes.
The evidence (5)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Avner S, Robbins T 2025 · Clin Med Insights Endocrinol Diabetes | observational | contradicts | low | Scoping review: most healthy individuals maintain normal glucose; value of CGM in non-diabetics uncertain; grey literature (influencers) overstates spike harm vs medical literature. |
| Ahmed N, Elzein Ali MF, Hamed Mohamed MN, Mohammed Saad Aldeen RSA, Ibrahim Omer RI, Adam Omer TM, ElTahir Hamza RA, Musa Rabih MR 2025 · Cureus | observational | mixed | moderate | CGM can personalize exercise timing and boost motivation in non-diabetics (surrogate glucose improvements) but no demonstrated benefit on hard health outcomes; benefit claim remains soft. |
| Keshet A, Shilo S, Godneva A, Talmor-Barkan Y, Aviv Y, Segal E, Rossman H 2023 · Cell Metab | observational | contradicts | high | CGMap characterization of 7,000+ non-diabetic adults shows healthy glucose ranges are narrow, providing reference values rather than evidence of intervention benefit. |
| Wilczek F, van der Stouwe JG, Petrasch G, Niederseer D 2025 · Sensors (Basel) | observational | tested-null | moderate | CGM in healthy non-diabetics: data scarce, cardiovascular benefit unproven; only potential role in guiding lifestyle. |
| Liao X, Li Y, Tang S, Xiao Y, Yu X, Huang R, Zhong T 2026 · Eur J Med Res | meta-analysis | contradicts | moderate | SR+meta-analysis of CGM in non-diabetic populations: effectiveness on glycemic parameters, body weight and behavioral outcomes remains unclear/not demonstrated. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.